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Abstract 
SNAMA, the protein of interest in this thesis is found in the common model organism 
Drosophila melanogaster, also known as the fruit fly it is also found in all eukaryotic 
organisms but not in prokaryotes. SNAMA is a 1231 amino acid protein that belongs to the 
RbBP6 superfamily. Members of this family are characterized by a zinc finger motif, a 
DWNN domain (domain with no name) and a RING finger motif. The human RbBP6 
contains the Rb-binding and p53-binding domains in addition. The mammalian RbBP6 hence 
interacts with p53 and Rb and it is important for the development and tumorigenesis as a 
negative regulator of p53. Bioinformatics studies show that transcription of the Snama gene is 
driven by a single TATA-less promoter which give rise to a single 3.9 kb transcript. 
However, experimental evidence confirming the promoter region has not being published. 
The main aim of this study was to examine the regulation of Snama by identifying the 
maximal promoter sequence that shows promoter activity in mammalian cell line. This was 
achieved by using specifically designed primers to amplify the putative Snama promoters, 
ligating promoters in reporter vector (pGL3 basic). The recombinant products used to 
transfect eukaryotic cells (Cos7, African green monkey cells) and determining the maximal 
promoter sequence that expresses luciferase activity. The promoter sequences were labeled 
with biotin attached to the primers and Electrophoretic mobility shift assay (EMSA) was 
conducted to confirm binding of proteins on the putative promoter fragments. The segment 
designated promoter 6 has maximal positive activity and many proteins in the cell extract 
bind to it shown by EMSA. Interestingly the longer fragment designated promoter 7 has less 
promoter activity. This may suggest that this fragment also contains some repressive 
elements.  
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1. Introduction 
Retinoblastoma binding protein 6 (RbBP6) is a protein that is encoded by the RbBP6 gene. 
The gene is thought to be associated with cell proliferation and such genes are overexpressed 
in the development of cancer. The regulation of p53 through mdm2 has been reported to be 
under the control of RbBP6 (Motadi et al, 2011). The RbBP6 gene encodes 3 isoforms of the 
protein and the third isoform (Isoform 3) is down-regulated in human cancers. The 
overexpression of RbBP6 results in increased G2/M cell cycle arrest whilst the knock-down 
results in reduced G2/M cell cycle (Mbita et al, 2012). 
 
For centuries scientists have been studying the interaction between various organisms, the 
environment they live in and the intricate details of their systems. Organisms that are used as 
model organisms are a small fraction of the biodiversity of the earth, although the research 
that results from the study of these organisms is of great importance and forms the core of the 
biodiversity knowledge. Independent research communities have a common interest in 
understanding the evolution, genetics and the development of these organisms. This research 
also forms the basis of comparisons between closely related and distantly related organisms. 
These studies have greatly benefited the field of evolutionary biology in which the molecular 
data has clarified estimates of phylogenetic relationships. Organisms such as the mouse and 
Drosophila are mostly used as model organisms, due to their small size and short generation 
times (Hedges, 2002; Wong et al, 2007).  
 
Insects make ideal model organisms as much is known about their natural history, 
physiology, genetics and behavior. They are also inexpensive to maintain and reproduce 
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rapidly (Morgan, 1910). Additionally, insects are of great interest due to their ability to resist 
pathogenic microorganisms at the cellular and humoral levels (Tweedie et al, 2009) hence 
this study was done to investigate the regulation of RbBP6 in Drosophila melanogaster. 
 
1.1. Drosophila melanogaster 
Drosophila melanogaster which is commonly known as the fruit fly is one of the species 
which are mostly studied in molecular biology of eukaryotes. Twelve members of the genus 
Drosophila have been completely sequenced (Wong et al, 2007) and the sequenced genomes 
stored in various databases such as flybase (Tweedie et al, 2009). Drosophila melanogaster 
belongs to the family Drosophilidae, the order Diptera and it is classified as an insect. The 
use of Drosophila as a model organisms began in the early 1900s. It was used in the generic 
research on sex linkage and genetic recombination by Thomas Hunt Morgan (Morgan, 1910). 
 
Another useful feature of Drosophila melanogaster, is the numerous techniques that can be 
used to manipulate the organisms genes and this is one of the other reasons D. melanogaster 
is a model organism of choice in genetic studies of eukaryotes. In every organism there are 
biological processes that need to be maintained to ensure the normal functioning of the 
organism in events such as death, growth and defense against diseases. Apoptosis and the 
ubiquitin pathway are some of the processes involved in these actions.  
 
Developments of most of the structures of the adult fly occur during the larval period and 
take their final form during eclosion. The central nervous system is an exception to this. 
Discs known as imaginal discs are a group of cells that invaginate from the embryonic 
ectoderm and form histoblasts and imaginary rings. The familiar external structures of the 
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adult fly develop from the imaginary discs (figure 1). The life cycle takes about 4-6 weeks. 
The eggs are about 0.5mm and the larvae take about 5 days to grow.  The fruit fly feeds on 
microorganisms that decompose fruit. The larvae then encapsulate in the puparium and 
undergo metamorphosis for 5 days. The adults emerge after metamorphosis (Mather et al, 
2005). 
 
 
 
Figure 1: Developmental stages of Drosophila melanogaster (Flagg, 1988).  
 
Due to the reasons above Drosophila melanogaster was chosen as a model of choice the 
following study. 
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1.2. Retinoblastoma binding protein 6 family 
This family of proteins is found in eukaryotes and absent in prokaryotes (Pretorius et al, 
2011) and members of this family are characterized by a zinc finger motif, a DWNN domain 
(domain with no name) and a RING finger motif. One of the proteins of interest in D. 
melanogaster is SNAMA which is inadequately uncharacterized and believed to belong to the 
RbBP6 protein family. The human homologue belonging to this family is a 250-kDa human 
protein known as the human Retinoblastoma binding protein 6 (RbBP6) (Pugh et al, 2006). 
The domain structure of this family of proteins is illustrated in figure 2. 
Figure 2: The RbBP6 family of proteins domain structure. Members of this family contain a DWNN domain, a 
zinc knuckle and a RING figure motif. A long C-terminal extension with p53 is observed in both insects and 
vertebrates and Rb- interaction domains in humans and mouse (Pugh et al, 2006). 
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The RbBP6 has a ring finger domain and has been identified as a putative E3 ubiquitin ligase. 
Studies have indicated that it is a multifunctional protein that interacts with p53 and pRb and 
has been implicated in the processing of pre-mRNA. Although the function of RbBP6, also 
known as p53 associated cellular protein testes (PACT) derived in mouse, is unclear, it is 
implicated in tumourigenesis, and is believed to play a role in the cell cycle. The mechanism 
by which RbBP6’s influences the cell cycle is also unclear (Chibi et al, 2008). PACT is 
highly up regulated in esophageal cancer and maybe a promising target for immunotherapy 
(Li et al, 2007).   
 
There are a few proteins known to interact with both tumour suppressor proteins pRb and 
p53. RbBP6 inhibits the binding of DNA to p53 by binding to wild type p53. RbBP6 also 
plays a role in facilitating the interaction of p53 and its primary regulator Hdm2. This leads to 
the ubiquitination and degradation of p53 by the proteasome (Chibi et al, 2008).  
 
Chibi et al (2008) conducted a study that described the novel interaction between DNA 
binding protein B (dbpB) and RbBP6. It was found that dbpB falls in the family of cold-
shock proteins and is a transcriptional factor that binds to the inverted CCAAT box. It is 
responsible for cellular functions such as the regulation of transcription and translation in 
response to stresses that result from extracellular signals. These orthologues of SNAMA have 
highly similar N-terminal domain configuration, suggesting that SNAMA is a member of this 
distinct family of proteins and thus plays a role in apoptosis and development in Drosophila. 
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1.3. SNAMA 
The name SNAMA is a Xhosa word that means something that sticks like glue. SNAMA was 
identified during homology searches using a sequence identified from a promoter trap 
mutagenesis screen for apoptotic genes in Chinese hamster ovary (CHO). The predicted D. 
melanogaster protein consists of 1231 amino acids and a molecular weight of 139 kDa. At 
the N-terminus SNAMA has the conserved 76 conserved amino acid Domain With No Name 
(DWNN). This is followed by a C2HC zinc finger motif, a RING finger-like motif and a C- 
terminal that is highly rich in lysine residues (figure 3) (Mather et al, 2005).  
 
 
 
 
 
Figure 3: Schematic representation of the internal domain structure of SNAMA in Drosophila melanogaster 
(Mather et al, 2005) 
 
The DWNN has an ubiquitin-like fold and is suspected to modify other proteins at least in the 
human version. This is because this domain exists as an independent module in one of the 
three isoforms. Although the DWNN domain is highly conserved throughout eukaryotic 
species, it is absent in prokaryotes (Pugh et al, 2006). DWNN has a 22% identity with 
ubiquitin and has an exposed C-terminal tail that extends beyond the  sheet of ubiquitin but 
lacks the conserved di-glycine peptide, which is essential for recognition of hydrolases. The 
di-glycine peptide is replaced by a conserved proline (Mather et al, 2005). This may indicate 
that DWNN is not cleaved off in biological reaction involving SNAMA.  
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The zinc finger motif tends to be involved in the interaction between protein-DNA and 
protein-protein (Matthews et al, 2001). The RING finger domain of SNAMA is slightly 
different to other RING finger motifs in that the histidine residue is substituted. This motif is 
normally found with a serine residue on the fourth ligand (figure 4) (Mather et al, 2005). The 
RING finger ligases have been shown to be RING finger motif dependant and it is suspected 
that the RING finger-like domain of SNAMA functions as an ubiquitin ligase dispite its 
uncharacteristic RING figure motif. 
 
 
Figure 4: Schematic representation of RING finger motif of SNAMA, Two zinc ions are coordinated by 
cysteine residues (yellow spheres) and a serine residue (orange sphere) that replace the lysine (Mather et al, 
2005). 
 
The DWNN domain is found in both SNAMA and the human Retinoblastoma binding 
protein 6 (RbBP6), indicating homology between SNAMA and the human RbBP6. This 
protein interacts with p53 and retinoblastoma (Rb) in both mouse and humans and it also 
functions in the regulation of the cell cycle and the induction of programmed cell death or 
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apoptosis (Mather et al, 2005). A homologue of SNAMA was described in yeast which is 
involved in the 3’ end processing of mRNA  (Vo et al, 2001). 
 
1.3.1. Work done on SNAMA and its homologues 
Although the regulation of SNAMA is not clearly understood, a study done by Hull & 
Ntwasa (2010) shows that there are similarities between regulation of SNAMA and RbBP6 
(Hull & Ntwasa, 2010). SNAMA orthologues are known to bind p53 and its orthologue  in 
mouse, RbBP6 is known to negatively regulate p53 by enhancing Mdm2 which regulated p53 
(Hull & Ntwasa, 2010). Hence SNAMA is proposed to play the role of Mdm2 in 
invertebrates. SNAMA is also believed to suppress apoptosis in early Drosophila 
development. The disruption of SNAMA leads to early apoptosis in Drosophila embryos. In 
the study mentioned above camptothecin and methyl-pyruvate treatment were conducted and 
transcriptional activation of SNAMA, Dmp53 and Reaper measured during and after 
recovery from treatment. It was found that the transcription of SNAMA is reduced during 
treatment but upregulated after recovery. Dmp53 transcriptionally controls Reaper. The 
camptothecin treatment causes an increase in the transcription of Dmp53 but there was no 
concomitant increase in Reaper mRNA. The methyl-pyruvate treatment resulted in the 
accelerated decline of Dmp53 transcription and the activation of SNAMA transcription (Hull 
& Ntwasa, 2010).  
 
Previously completed work by Ntwasa and Antunes gives insight into transcriptional 
regulation of Snama through the analysis of the core promoter elements surrounding the 
transcription start site (TSS). The 5’ RACE was used to delineate the TSS. Furthermore, 
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using bioinformatics Mather et al., 2005, showed the transcription start site of SNAMA by 
predicting TSS to be in the region determined by 5’ RACE. This transcription start site is 
believed to be regulated by a TATA-less promoter. The TATA-less promoter region contains 
core elements Inr and DPE that are needed for binding of the transcription initiation factor 
TFIID. Antunes work showed that SNAMA is regulated by a single TATA-less promoter that 
gives rise to an approximately 3.9 kb transcript (Antunes, 2008). 
 
1.4. Apoptosis, programmed cell death 
For an organism to function optimally there are a number of processes that need to occur in 
order to maintain homeostasis. One of these processes, apoptosis, is a mechanism of 
controlled cell deletion. Damaged, unwanted cells are removed to allow proliferation of 
normal cells (Wyllie, 1993). Apoptosis appears to play an opposite but complementary role to 
mitosis in the regulation of animal cell populations. Pathological and physiological 
environmental stimuli can inhibit or initiate apoptosis. It involves the rapid condensation and 
budding of the cell by forming apoptotic bodies that are enclosed in a membrane containing 
well preserved organelles (John Bright & Khar, 1994). Nearby resident cells then digest and 
engulf the remains of this apoptotic cell. The process involves the cleavage of double 
stranded nuclear DNA resulting in oligonucleosomal fragments. Inhibitors of  mRNA and 
protein synthesis can suppress the apoptotic process (Kerr et al, 1994). 
 
There are two phases that apoptosis can be divided into, the initiation phase and the effector 
phase. The initiation phase depends on the type of stimulus that induces apoptosis. The 
effector phase is characterized by DNA fragmentation and morphological changes to the 
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cells. Both these phases involve the action of specific enzymes called caspases, with caspase 
3 playing a key role in the effector phase (Koyama et al, 2000).  
 
1.5. Ubiquitination 
Damaged proteins are tagged for degradation by a 76 amino acid protein named, ubiquitin. 
The amino acid sequence of the protein is highly conserved across species and it is found in 
all eukaryotic cells. Ubiquitin is heat stable due to its three and a half α-helix, a short piece of 
3(10)-helix, seven reverse turn and five mixed strands of β sheets (figure 5). The overall 
structure is tightly bonded by hydrogen atoms.  
 
 
 
Figure 5: The three dimensional structures of ubiquitin showing its helices (red), 5 β-sheets (yellow) and seven 
reverse turns (blue). 
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Ubiquitin tags damaged proteins for degradation by 26S proteasome. The 26S proteasome in 
the nucleus is covalently attached to histones believed to function in the regulation of 
transcription. The degradation of proteins by the ubiquitin process involves two consecutive 
steps which are: (1) tagging of the protein substrate by molecules of ubiquitin and (2) the 
degradation of the tagged proteins by the 26S proteasome, which recognize ubiquitinated 
proteins, resulting in the release of reusable ubiquitin and inactive peptides. The tagging 
involves the attachment of ubiquitin via the glycine on the C-terminal 4-residue tail, to the 
lysine of the target protein to form an isopeptide bond (Pickart, 2004).  
 
The ubiquitin pathway involves a series of enzymes that aid the binding and the degradation 
process. The first enzyme in the casade, the E1 activates ubiquitin on its C terminal glycine. 
The ubiquitin is activated on its C-termial glycine by a thioester bond with cysteine on the 
active site of E1. The ubiquitin  complex is then transferred from E1 to E2, which forms 
another thioester bond with the complex (Hershko et al, 1983). The covalent isopeptide bond 
between the ε-amino group and α-carboxyl group is catalysed by an E3, ubiquitin ligase. The 
ε-amino group is found on the side chain of a lysine residue of the protein substrate and the α-
carboxyl group is on the C-terminal of ubiquitin. Successive ubiquitin molecules are then 
attached to one another to form a polyubiquitin chain. The polyubiquitin chain molecules are 
linked via a Gly
76
-Lys
48
 isopeptide bond. The 26S proteasome complex recognizes the 
polyubiquitin chain as a signal for degradation (Hershko & Ciechanover, 1998). 
 
1.5. Drosophila melanogaster p53 (Dmp53) 
Dmp53 is a 42kDa protein with 385 amino acids. It was identified using its human 
homologue the human p53 (Ollmann et al, 2000). Homology searches in Drosophila 
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identified three isoforms of Dmp53 namely; dp53L, dp53 and dp53n (figure 6). The dp53L 
has two additional exons which make it longer than the other two isoforms and has a 
sequence on the N-terminal end that is conserved through evolution, the FxxψW. The 
sequence is required for the activation of gene transcription. Proteins from other vertebrates 
such as p53, p63 and p73 have the conserved FxxψW sequence, and dp53L share this feature 
with these proteins unlike dp53 where the FxxψW sequence is absent. The dp53 isoform is 
produced from an inner promoter and is truncated on the N-terminal. It is the second largest 
isoform with 385 amino acids. The last isoform, dp53n, is the smallest with only 123 amino 
acids; it is the splice variant of dp53L with no splicing of intron B (Bourdon et al, 2005). The 
internal promoter is implicated as playing an important role in the control of activities 
involved with the p53 gene family across species, since the internal promoter sequence is 
conserved throughout evolution from humans to Drosophila.  
 
Figure 6: A schematic representation of the three different Drosophila melanogaster p53 isoforms: dp53L, 
dp53, and dp53n (Bourdon et al, 2005). 
 
p53 is a tumor suppressor protein that has been characterized primarily as a sequence-specific 
transcription factor that is mutated in more than half of all human cancers (Levine, 1997). It 
is usually kept at low concentrations and increased upon cellular stress such as DNA damage 
and promotes apoptosis. Mouse double minute 2 (Mdm2) protein regulates p53 in mammals 
and it is believed to be the major physiological antagonist of p53. With the mdm2 gene being 
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the characterized target of the p53 autoregulatory negative feedback mechanism, where p53 
induces the expression of Mdm2, whereas Mdm2 represses p53 activity. This serves as a vital 
mechanism to inhibit p53 function in normal cells (Lahav et al, 2004). Mdm2 not only 
inhibits p53 but also promotes the degradation of p53 by catalyzing ubiquitination (Haupt et 
al, 1997), acting as an E3 ubiquitin ligase (Honda et al, 1997). This is achieved by complex 
binding with p53 at the N-terminal of Mdm2 and the binding of ubiquitin molecules on the C-
terminal end of p53 tagging p53 for degradation (Chen et al, 1995). 
 
SNAMA is likely to be a homologue of Mdm2 in Drosophila and therefore, a possible 
candidate for the regulation of Dmp53 and RBF, which is a homologue of Rb. RBF is 
regulated by ubiquitination and acts downstream of the transcription factor, dE2f, which 
functions in the regulation of Dmp53. Since the mouse and the human homologues of 
SNAMA have been shown to bind to p53 and Rb it is suspected that SNAMA interacts with 
Dmp53 and RBF, possibly playing a critical role in their regulation. Hence, a better 
understanding of how SNAMA is regulated will give an insight on its role in cancer and 
apoptosis. Characterisation of the full length promoter sequence of SNAMA would aid in the 
understanding of the expression and regulation of SNAMA.  
 
1.6. Luciferase Reporter assay for promoter analysis 
The luciferase reporter assay technology is useful in investigating questions related to the 
regulation of genes. Reporters are used to study expression of genes and cellular events that 
are coupled with expression of genes. In the technology a reporter gene is cloned with a DNA 
of interest into an expression vector. The vector is then transferred into cells and the presence 
of the reporter assayed. The presence of the reporter can be assayed by either measuring the 
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reporter protein or by enzymatic activity. Reporters such as bioluminescence reporters are 
ideal because they are sensitive and they are quick to measure. 
 
1.7. Luciferase Enzyme 
The luciferase enzyme evolved for the nocturnal mating behavior of beetles. This enzyme 
catalyzes a two-step oxidation reaction in order to produce light between 550-570nm, in the 
green to yellow region. The two oxidation steps are the activation of luciferyl carboxylate by 
ATP to yield a mixed reactive anhydride and the creation of transient dioxetane that breaks 
down into oxyluciferin and carbon dioxide (CO2). In the second step the transient dioxetane 
results from the reaction of the intermediate in the first step with oxygen (O2). The gene that 
encodes the firefly luciferase is a cDNA, luc that contains no introns and is available as a 
mature enzyme upon translation due to its lack of modification after translation. The 
luciferase gene, luc in the firefly was modified into luc+. This was due to the saturation of the 
peroxisomes, where the luciferase is directed. The saturation resulted in enzyme remaining in 
the cytoplasm creating a difference in enzyme stability between the peroxisomes and the 
cytoplasm. This lead to a concentration dependent relationship between protein synthesis and 
the quantity of luminescence (Sherf & Wood, 1994). The two luciferase reporters of interest 
are the (i) Firefly and the (ii) Renilla luciferase. 
(i) Firefly luciferase, is a 61kDa monomeric enzyme from the firefly 
(Photinus pyralis). It is mostly used as a bioluminescent reporter in 
molecular biology due to the convenience of the assay, sensitivity and 
the coupling of protein synthesis with the enzyme activity 
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(ii) Renilla luciferase is a 36kDa protein which was originally cloned from 
the marine Renilla reniformis. This luciferase does not require post-
translation modification for activity. Hence due to renilla luciferase’s 
similarity to the firefly luciferase it can function as a generic reporter 
immediately after translation. 
 
There are four possible luciferase assays that can be conducted: Bright-Glo, Steady-Glo, One-
Glo and Dual-Glo luciferase assay system. The Bright Glo Luciferase assay system quantifies 
the luciferase expressed by providing 10 fold more light output than other reagents that have 
extended half-life such as the Steady-Glo single-reporter reagent. The extended half-life of 
Steady-Glo allows batch processing of assays and does not require luminometers with 
injectors. The One-Glo luciferase assay also has extended half-life (Wood, 1998). 
 
The fourth assay (Dual-Glo luciferase assay) was the assay of choice since it is engineered to 
normalize the expression of reporters. The reporters in the assay are experimental (Firefly) 
and the control (Renilla) reporter which give insight on specific and non-specific cellular 
responses. The two are widely used as co-reporters for normalization studies due to their 
sensitivity and quick and easy to use nature. The maximal promoter sequence was identified 
after using Dual luciferase assay. 
 
Reporter genes can be used for a multitude of processes (figure 7) and they require reporter 
vectors such as pGL3 and pRL vectors. The pRL vectors contain a cDNA (Rluc) Renilla 
luciferase. There are four vectors belonging to the pGL3 family (see appendix, 5.2) and four 
belonging to the pRL family (see appendix, 5.2) that contain the luciferase gene. 
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Figure 7: Schematic representation of a range of applications for reporter genes in cellular biology (Sherf & 
Wood, 1994). 
 
1.8. Aims 
This study aimed to examine the regulation of the Snama gene in Drosophila melanogaster 
by identifying the maximal promoter sequence using designed Snama primers. Sequentially 
truncated regions of the putative promoter sequence of Snama were individually amplified 
and cloned into both pGem-T-easy and pGL3 basic reporter vector. Eukaryotic cells (Cos7 
cell lines) were transfected with the pGL3 clones and assayed for luciferase expression. The 
longest promoter sequence which induced luciferase expression was considered to contain the 
core promoter elements of Snama. Promoter sequences were also used for EMSA to identify 
whether there are proteins that bind to the biotin labeled probes. These proteins would then 
represent the transcription factors that bind to these promoters. The proteins that bind were to 
be identified by mass spectroscopy and would give insight of their interaction with SNAMA. 
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2. Materials and Methods 
2.1. Growth media 
Table 1: Growth media 
Media Composition 
Apple juice agar 1.25% sucrose; 2% agar; 0.025% 
streptomycin; 0.15% methylparaben (3g 
dissolved in 30 ml ethanol and made up to a 
litre); 25% apple juice (v/v). 
Luria-Bertani broth (LB) 1% tryptone powder; 0.5% yeast extract 
powder; 1% NaCl; mix and autoclave. 
LB agar (LA) LB + 1.5% agar; autoclave. 
Cos7 cells (mammalian cells) 3:1 ratio of DMEM : Ham’s F12, 10%FBS, 
1% penStrep 
 
2.2. Buffers and solutions 
Table 2: Molecular biology buffers and solutions. All reagents were stored at room temperature and made up 
with deionized water unless indicated. 
Buffer Composition 
Coomassie blue stain 0.1% Coomassie blue R-250; 40% ethanol; 
10% glacial acetic acid. 
DNA loading dye (10X) 0.21% Bromophenol blue; 0.21% xylene 
cyanol FF; 50% glycerol; 0.2 M EDTA, pH 
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8.0; store at 4ºC. 
Electrode (running) buffer (5X) 125 mM Tris base; 1 M glycine; 17 mM 
SDS; pH to 8.3 with HCl.    
Embryo wash (10X) 0.7% NaCl, 0.04% triton-100 
Grinding buffer 5% sucrose, 80mM NaCl, 100mM Tris pH 
8.5,0.5% SDS, 50mM EDTA 
Miniprep solution I 5 mM sucrose; 10 mM Na2EDTA-2H20; 25 
mM tris; pH to 8.0 with NaOH.  
Miniprep solution II 0.2 M NaOH; 1% SDS; prepare fresh. 
Miniprep solution III 3 M sodium acetate, pH 4.8 made up with 
acetic acid. 
Phosphate buffered saline (PBS), 50X  1.4 M NaCl, 27 mM KCl, 101 mM Na2HPO4, 
18 mM KH2PO4, pH to 7.3 with HCl. 
Protein extraction (Nuclear) Buffer I plus 
inhibitors 
1mM DTT, 0.1mM EDTA, 15mM HEPES-
KOH pH 7.6, 10mM KCl, 5mM MgCl2, 
100ug/ml PMSF, 2ug/ml Aprotinin, 50ug/ml 
Leupeptin, 0.35M Sucrose 
Protein extraction (Nuclear) Buffer II plus 
inhibitors 
0.1mM EDTA, 15Mm HEPES-KOH pH 7.6, 
10mM KCl, 5mM MgCl2. 0.8M Sucrose, 
1mM DTT, 50ugml Leupeptin, 2ug/ml 
Aprotinin, 100ug/ml PMSF 
SDS sample buffer (5X) 1 M Tris-HCl, pH 6.8; 10% glycerol; 10% 
SDS; β-mercaptoethanol; 1% bromophenol 
blue; store at 4ºC. For Native gel (SDS 
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sample buffer + 0.024g/ml Urea) 
 
2.3. Chemicals and kits 
Table 3: Chemicals, enzymes and their suppliers 
Chemical/Enzymes/Kit Supplier catalogue numbers 
Agarose SBS Genetic co. GA4-100 
Dual-Luciferase
®
 Reporter Assay System Promega E1910 
GeneRuler
TM 
100bp DNA ladder plus  Fermentas SM0321 
LightShift Chemiluminescent Thermo scientific 89880 
PageRuler
TM
 prestained protein ladder Fermentas SM0671 
pGEM
®
-T Easy vector system Promega A1380 
pGL3 basic reporter vector Promega E1751 
pRL Renilla Luciferase Reporter Vectors Promega E2241 
Streptravidin
®
 agarose Sigma alderich S1638-1ML 
Trypsin/Versene Highveld biological 205A 
Zymoclean Gel DNA Recovery kit Zymo research corporation D4001S 
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2.4. Cell culture 
Table 4: Cell culture 
Strain Supplier 
Cos7 cells (mammalian) Elsabe 
 
2.5. Bacterial strains 
Table 5: Bacterial strains 
Strain Genotype 
Escherichia coli XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZΔM15 Tn10 
(Tetr)] 
2.6. Bioinformatics analysis of Snama gene 
The Snama gene was analysed using DNAman and following analysis the primers for 
putative Snama promoter designed. The designed primers were purchased from Inqaba Biotec 
and are indicated in table 6 below. 
 
Table 6: Oligonucleotides used for PCR and sequencing.  All the primers were used unlabeled and labeled with 
biotin except for the reverse primer.  
Oligonucleotide Sequence 
Snama primer 3 5'-CAGAAATGCAGATCTGCTGCC-3' 
Snama primer 4 5'-CGTATTTACTGCAGATCTAGAG-3' 
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Snama primer 5 5'-GACTAAATTAGATCTGCATCGA-3' 
Snama primer 6 5'-GCAAAGATCTAAAAGGCGGTG-3' 
Snama primer 7 5'-GCCTCCTTAAGATCTATTCG-3' 
Snama reverse primer 5'-GAACGTGAAGCTTAAGCCC-3' 
 
2.7. Isolation of Drosophila melanogaster genomic DNA 
Fifty adult fruit flies reared at 25˚C on standard commercial apple juice agar with yeast were 
homogenized in 500µl grinding buffer. The homogenate was incubated at 70˚C for 30 
minutes. Following incubation, 87µl of 8M KOAc was added and the mixture was placed on 
ice for 30 minutes and centrifuged at 13000g for 10 minutes. The supernatant was collected 
and the DNA was precipitated with isopropanol. The tube was left to stand at room 
temperature for 10 minutes, spun at room temperature for 10 minutes at 13000g and the 
supernatant discarded. The DNA pellet was washed with ethanol and left to dry 37˚C for 2-3 
minutes. Subsequently the pellet was resuspended in 100ul nuclease free water (Bender et al, 
1983). The genomic DNA was stored in the -20˚C freezer until needed. 
 
2.8. Amplification of putative Snama promoters 
Snama promoters were amplified by Polymerase chain reaction (PCR) for 40 cycles. PCR is a 
technique used to amplify a DNA fragment of interest, in order to isolate and produce more 
of this target DNA for further experimentation. PCR is a three step process which consists of 
denaturation, annealing and elongation. During denaturation, DNA is heated until it separates 
into two strands to allow the primer to anneal. Taq polymerase catalyses the elongation of the 
two strands. DNA isolated from the fruit fly was used in the PCR run and primers which were 
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specific for putative promoters of Snama. The PCR mixture and the PCR conditions are 
indicated in the following tables. 
 
Table 7: The reaction mixture used for PCR 
Reagent Concerntration of 
stock solution 
Volume added (µl) Concerntration 
in final mixture 
(50µl) 
dH2O - 38 - 
Taq buffer 10X 5 1X 
dNTP’s 10mM 1 0.2mM 
MgCl2 25mM 2 1mM 
Forward primer 100µg/µl 1 2 µg/µl 
Reverse primer 100µg/µl 1 2 µg/µl 
Template DNA 100ng/µl 1 2ng/µl 
Taq polymerase 5 units/µl 1 5 units 
 
Table 8: The temperature profiles used for PCR 
Cycle Temperature (◦C) Duration (sec) 
Taq polymerase activation 94 600 
Denaturation 94 30 
Annealing 60 30 
Extention 72 60 
Final extension 72 420 
Holding step 4 ∞ 
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2.9. Gel electrophoresis 
Agarose gel electrophoresis is a method used to separate DNA bands according to their 
molecular sizes. The products from the PCR were separated on a 1% agarose gel, dissolved in 
1x Tris-Acetic acid Ethylenediaminetetraacetic acid (TAE). The separated PCR fragments 
were recovered and DNA bands were extracted from agarose gels with the aid of gel 
extraction kits. The promoter sequences were gel purified using the Zymoclean gel recovery 
kit following manufacturer’s instructions. The purified DNA was used to perform for 
ligations. 
 
2.10. Ligation of promoter sequences 
Ligations were conducted to insert the purified DNA into a vector for expression purposes. 
The extracted promoter sequences were ligated into the pGEM-T easy cloning vector. These 
promoter sequences were then digested out of pGEM-T Easy vector with EcoRI (a sticky end 
cutter, Fermentas) and blunt ended with Klenow enzyme (Roche). The pGL3 basic vector 
was linearized using SmaI (a blunt end cutter, Roche) and dephosphorylated. The blunt ended 
promoter sequences were ligated into the dephosphorylated vector and the ligation reactions 
were used for transformation. 
 
2.11. Transformation of products 
The ligated promoter sequences in pGEM-T Easy were transformed into competent 
Escherichia coli bacterial cells. Transformed cells were platted on luria bertani agar (LA) 
amended with 50ug/ml ampicillin, 0.2 mM IPTG and 40ug/ml X-gal for selection of blue and 
white colonies.  
24 
 
 
The transformation was conducted according to the procedure of (Sambrook & Russell, 
2001). Controls were used to confirm success of the transformation. Clones containing 
recombinant plasmid DNA were indicated by white colonies.  
 
Fresh bacterial cells (XL-1 Blue cells) were made competent as per (Sambrook & Russell, 
2001) method, prior to the transformation in order to allow efficient transformation. Plasmid 
DNA was isolated using the alkaline lysis method (Birnboim, 1983). Double digestions were 
performed with HindIII and Kpn1 (Fermentas) in order to confirm the presence of the 
promoter sequences in the pGL3 basic vector. 
 
2.12. Small scale plasmid preparation 
Plasmid DNA was isolated using the alkaline lysis method (Birnboim, 1983) and the DNA 
concentration was determined based on the absorbance of light at 260 nm. The prepared 
mini-prep was used for digestions. The digestion reactions were conducted in order to verify 
the availability of the promoter sequences (insert). After successful digestion (verified from 
agarose gel electrophoresis, 1% agarose) the miniprep was sent for automated sequencing in 
order to verify that the promoter sequences were correct and no mutations had occurred. 
Large scale plasmid preparations (maxipreps) were performed in order to have promoter 
sequences in large amounts for further experimentation. The recombinant DNA was used for 
transfection of eukaryotic cells, Cos7 cell line. 
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2.13. Transfection of eukaryotic cells with recombinant pGL3 basic 
reporter vector 
Cos7 cells (5x10
5
 cells/ml) were seeded in 60mm tissue culture dishes at 37˚C, 5% CO2 prior 
to transfection. A total of 5ug of DNA (pGL3 basic vector recombinant and pRL-TK 1:20) 
was diluted in cell growth media with neither antibiotic (penStrep) nor serum (FBS) to a 
volume of 150ul. To this 30ul of superfect transfection reagent (Qiagen) was added and the 
mixture was incubated for 10 minutes at 25˚C. While complexes were forming media was 
aspirated from cells and cells were washed with 1X PBS. Following the formation of 
complexes 1ml of media with serum (FBS) and antibiotics (penStrep) was added and mixed. 
The total volume was added to the cells in 60mm dishes with cells and incubated for 3hours 
at 37˚C 5% CO2. After incubation the media containing the remaining complexes was 
aspirated and cells washed with 1X PBS. Fresh growth media was added to the cells and cells 
were incubated under normal growth conditions (37˚C and 5% CO2) for 48hours. After 
48hours the luciferase assay was performed. 
 
2.14. Expression of luciferase 
The pGL3 luciferase reporter vector has been used to quantify the level of gene expression in 
eukaryotic cells. The vector contains a modified coding region for Photinus pyralis luciferase 
that has been optimized for monitoring the activity of transcription of eukaryotic cells that are 
transfected as its backbone is designed for increased expression (Groskreutz et al, 1995). It 
also lacks a eukaryotic promoter and the resulting luminescence is rapid, sensitive and 
quantitative in nature.  
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The Dual-Glo Luciferase Assay Syatem was used to quantify the level of expression of 
luciferase in the pGL3 luciferase reporter vector system.The Dual-Glo Luciferase Assay 
System was used to measure the two assays, the Firefly (Experimental, pGL3 basic) and 
Renilla (Positive Control, pRL-TK). Luminescence in the luciferase assay was measured with 
a luminometer. For the assay growth media was aspirated from the cells and the cells were 
washed with 1X PBS prior to the addition of 400µl of passive lysis buffer (PLB). Cells were 
scraped off and added to an eppendorf tube. 100µl of Luciferase Assay Reagent II (LARII) 
was added to each well of the 96 well luminometer plate. The PLB lysates were mixed and 
20µl of each reaction was added to the LARII in the 96 well plate and the luminescence of 
the Firefly luciferase was measured. The plate was removed and 100µl of Stop and Glo 
reagent added and the luminescence of the Renilla luciferase was measured. 
 
2.15. Preparation of protein extracts  
Prior to protein extraction, Drosophila melanogaster embryos aged from 0-6 hours were 
collected from an apple juice agar and yeast. The embryos were washed off the dish with 1X 
embryo wash, dechorionated using 5% bleach and rinsed with 1X embryo wash. The 
embryos were rinsed with dH2O and transferred to a microcentrifuge tube and left to settle. 
The rinse solution was aspirated and buffer I with inhibitors was added and the mixture was 
kept on ice. The embryos were homogenized using 7-10 strokes of a tight fitting pestle on ice 
at 4˚C until the suspension became milky. The homogenate was poured into a 
microcentrifuge tube and spun at 7.700x g for 15 minutes at 4˚C to pellet the yolk and the 
nuclei. The supernatant was removed (cytoplasmic extraction) and stored at -70˚C.  The top 
white layer of the yolk which contained the nuclei was removed without disrupting the yolk. 
Buffer I with inhibitors was added to the nuclei and homogenized with 4 strokes of the pestle. 
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The homogenate was layered on top of buffer II plus inhibitors in a new microcentrifuge tube 
and centrifuged at 1.310x g for 30 minutes at 4˚C. The supernatant was aspirated and the 
pellet resuspended in buffer I and stored at -70 ˚C until needed.       
 
2.16. EMSA 
Electrophoresis mobility shift assay (EMSA) is the use of electropherisis to detect complexes 
between nucleic acid and protein. The electrophoresis is carried out on either a 
polyacrylamide or an agarose gel. Generally complexes of labeled nucleic acids and proteins 
migrate slower than unbound nucleic acids. The assay is a rapid and sensitive method used to 
detect nucleic acids and protein complexes (Hellman & Fried, 2007). An EMSA kit (Thermo 
scientific) was used with biotin labeled putative SNAMA promoters. The assay generally 
involved the preparation of binding reactions, electrophoresing of these reactions on a native 
polyacrylamide gel in 0.5X TBE and the transfer of the DNA to a nylon membrane. This is 
followed by the crosslinking of DNA to the membrane and the detection of biotin-labeled 
DNA by chemiluminescence. The protocol was carried out as per manufacturer’s 
instructions. 
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2.17. Treatment of Cos7 cells with compounds 
The Cos7 cells were treated with different compounds and concentrations see table below: 
 Table 9: Concentrations of additives used to treat Cos7 cells. 
 Cos7 (1) Cos7 (2) Cos7 (3) 
Camptothecin 1uM 5 uM 10 uM 
Methyl pyruvate 1mM 1mM 1mM 
DMSO 1% 1% 1% 
 
The table above shows the concentrations of the various additives used to treat Cos7 cells. 
The differences in the responses of the cells to these additives may be a consequence of these 
differences in concentrations. 
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3. Results 
In the first instance these results describe the analysis of the Snama promoter and establishes 
the segment with maximal promoter activity in Cos cells. Previous bioinformatics analysis of 
the putative regulatory region of Snama using the BDGP Neural Network Promoter 
Prediction programme, located on the web at http://www.fruitfly.org/seq_tools/promoter.html 
(Reese, 2001), indicated that the promoter region was located upstream of the start site 
predicted to be at position 1608 bp upstream from the transcriptional start site and had a score 
of 0.97 (Mather, 2005). The software relies on common eukaryotic 5' elements such as TATA 
boxes. Furthermore R. Antunes (Antunes, 2008) confirmed experimentally the TSS of Snama 
to be upstream the translational start site, using 5’ RACE. Based on this information I created 
truncated versions of the putative promoters regions beginning at the TSS to -672. Secondly 
EMSA shows that the promoter fragment with maximal activity binds the most proteins in 
cell extract compared to other fragments. Thirdly using exCELLegence technology this work 
showed that camptothecin (DNA damaging agent) causes death of cells and slow recovery of 
surviving cells. This work also shows that in a SNAMA promoter-dependent manner methyl 
pyruvate accelerates, somewhat the recovery process.  
 
3.1. Cloning of promoter fragments 
Primers were used to obtain truncated versions of the predicted Snama promoter to access the 
longest possible sequence upstream of the Snama transcription start site that could function as 
a promoter. The primers were designed to give rise to a series of sequences that were roughly 
100 bp truncations of the promoter region and each other (Table 8). 
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Table 10: Positions and sequences of Snama primers 
 
PCR was conducted to amplify the putative Snama promoter sequences. Promoters 3, 5, 6 
and 7 of Snama were amplified and the products of PCR run on a 1% agarose gel (Table 9, 
Column 1). The sequences were purified using a gel extraction kit from Qiagen and sent for 
sequencing and then cloned into pGem-T-easy. Amplification of promoter 4 was however 
unsuccessful hence no further experiments were conducted with this primer sequence. The 
bands for promoters 3 and 6, show bright bands of good quality DNA, while only faint bands 
were obtained for promoter 5 and 7. As expected the product obtained for primer 7 and the 
reverse primer was just smaller than 700 bp (672bp) with the product obtained using primer 6 
being approximately 100 bp shorter (552bp). The product obtained using primer 5 is a further 
100 bp shorter (454 bp) while that obtained using primer 3 is a further 200 bp shorter (231 
bp). 
 
Sequence Name Position Sequence 
Primer  Reverse -19 5' GGGCTTTGGCGTCACGTTC 3' 
Primer  1 (P1) -50 5' CCCGCGTGTGCGTTCGCAT 3' 
Primer  2 (P2) -129 5'CTAATAAAGTTCAATACTTTCACTT 3' 
Primer  3 (P3) -231 5' CAGAAATGCAGAATTGCTGCC 3' 
Primer  4 (P4) -332 5' CGTATTTACTGCAGCTTAAGAG 3'' 
Primer  5 (P5) -454 5' GACTAAATTAGGATTGCATCGA 3' 
Primer  6 (P6) -552 5' GCAAATATCGAAAAGGCGGTG 3' 
Primer 7 (P7) -672 5' GCCTCCTTACAATCCATTCG 3' 
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3.2. Luciferase assays to determine transcription activity 
To verify that the sequences were successfully cloned into the pGem-T-Easy, the vector was 
digested with restriction enzyme (EcoRI) from Roche (Table 9, Column 2) and visualized on 
a 1% agarose gel. The sizes of the restricted plasmid and insert were verified by comparing 
them with the molecular weight marker. The liberated inserts were purified and the cloned 
into the reporter vector pGL3 basic. The pGL3 basic vector contains the luciferase reporter 
gene. Cloning of the putative promoter sequences placed the luciferase gene under the control 
of these promoters. The sequences were digested out of the reporter vector by double 
digestion, using the restriction enzymes HindIII and KpnI. This was done in order to verify 
that the sequences had been ligated into the reporter vector (Table 11, Column 3). 
 
The Luciferase assay was to determine the maximal region to drive expression. Furthermore, 
EMSA was used to test whether this region can interact with proteins. Currently we are in the 
process of using affinity Chromatography and mass spectroscopy to determine and identify 
the proteins shown by EMSA to interact with the promoters.  
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Table 11: Gel electrophoresis results of Snama putative promoters to verify the clones. PCR products were 
cloned in pGem-T-Easy and pGL3 vectors. 
 
 
 
3.3. Determination of promoter activity by Luciferase reporter assay 
To determine the fragment with maximal promoter activity, the dual luciferase assay was 
carried out. The results are shown in figure 8. Cells were cultured until they reached a density 
of 1x10
5
 cells/ml (in 5 ml) and then they were transfected with 5µg of DNA. The ratio of the 
experimental vector to the control vector was 1:20. The dual luciferase assay measured firefly 
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and renilla luciferase sequentially using the Dual luciferase system from Promega (cat# 
E1910).  
 
The assay was carried out in triplicates following the instructions of the manufacturer. The 
data was pooled together to plot the graph using relative ratios (see below). The promoters 
that were investigated were promoters 5, 6 and 7. The graph shows that despite being the 
longest promoter sequence, promoter 7 was found not to express much luciferase activity in 
relation to the control (pGL3 basic). The second longest truncated promoter, promoter 6 was 
found to promote significant luciferase activity. The third truncation promoter 5 was found to 
behave like promoter 7 and did not show significant difference compared to the control. 
Therefore, promoter 6 was found to be the maximal promoter sequence expressing luciferase. 
The relative ratios used to plot the graph were calculated as follows: 
X = Control firefly luminescence 
       Control renilla luminescence 
 
Y = Experimental firefly luciferase 
         Experimental renilla luciferase 
 
  Relative Ratio = Y 
       X 
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Figure 8: Schematic representation of the primer positions in the upstream untranslated region of Snama and 
putative promoter activity. (A) Schematic representation of putative Snama Promoters (p5, p6 and p7), the 
positions are relative to the transcription start site (TSS)+1. (B) Dual luciferase assay to determine the maximal 
promoter sequence. Measurement of Luminescence activity of Firefly and Renilla luciferase activity indicated 
that the maximal promoter sequence required to initiate Snama transcription and expression, was promoter 6. 
Despite promoter 7 being the larger sequence that contained promoter 6 the luciferase activity detected, was no 
more than the activity detected in the control pGL3 in the figure. 
 
3.4. Possible Transcription Factors determined by Electrophoretic Mobility 
Shift Assay (EMSA). 
Having assessed the putative transcription region of Snama, potential transcription factors 
were identified using EMSA. PCR was performed using biotin labeled primers, in order to 
label promoter sequences with a probe which could be detected via chemiluminescence. The 
amplification of biotin labeled DNA sequences was confirmed via electrophoresis. These 
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PCR products of biotin labeled primers 3, 6 and 7 are shown in figure 9, the amplification 
with primer 5 was however unsuccessful. Promoter 6 produced a bright band of good quality 
DNA whilst the other two promoters (promoter 3 and 7) produced faint but visible bands. 
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Figure 9: Agarose gel of PCR products of Snama putative promoters with biotin labeled primers. The gel shows 
amplified promoters 3, 6 and 7. The products are the expected size.  
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Nuclear protein extracts from Drosophila embryos were reacted with the biotin labeled 
putative promoter sequences. To establish whether any proteins bound to the promoters, an 
EMSA was carried out by running the reactions on a 6% native polyacrylamide gel and 
transferring the DNA to a nylon membrane. The biotin labeled DNA was detected by 
chemiluminescence and the results are shown in figure 10. The shift on the film indicates that 
there are proteins that bound to the biotin labeled DNA sequences. 
 
The results that were obtained for the control system were as expected as per manufacturer’s 
manual.  Control 1 consisting biotin-EBNA control DNA in lane 1 showed no shift. Control 2 
in lane 2 consists of biotin-EBNA control DNA and EBNA extract, contains sufficient target 
protein to effect binding and shift of the biotin-EBNA DNA as compared to the shift detected 
in control 1. Finally control 3 consisting of biotin-EBNA control DNA, EBNA extract and 
excess unlabeled EBNA DNA is found in lane 3, this result demonstrates that the signal shift 
observed in control 2 can be prevented by competition from excess non-labeled DNA. For all 
the promoter reactions shifted bands were observed for the promoter sequences. This 
observation shows a shift of DNA in all three was due to binding of proteins. As expected the 
unlabeled promoters, with no biotin label, gave no signal. 
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Figure 10:  X-ray film showing detection of mobility shift of labeled promoter sequences reacted with nuclear 
protein extracts.  Mobility shift assay of Biotin labeled and unlabeled DNA sequences of Snama promoters are 
indicated in the different lanes. Lane 1-3 indicates the EBNA control system, Biotin-EBNA Control DNA, 
Biotin- EBNA Control DNA and EBNA extract and Biotin-EBNA Control DNA and EBNA extract with excess 
unlabeled EBNA DNA respectively. The biotin-EBNA control DNA shows no shift, biotin-EBNA control DNA 
and EBNA extract shows a shift and the biotin-EBNA control DNA and EBNA extract and excess unlabeled 
EBNA DNA shows minimal shift due to competition. Lane 4-6 shows the unlabeled DNA fragments P5, P6 and 
P7. These unlabelled promoters do not give any signal. Finally, lanes 7-9 containing the labeled promoters P5, 
P6 and P7, indicate a mobility shift due to the binding of Drosophila nuclear proteins to the promoters. 
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3.5. Bioinformatics analysis of Transcription binding sites 
Using the Model Inspector software from Genomatix, the possible TF’s matches that could 
bind to Snama were predicted and the predictions are indicated in the figure below (figure 11) 
whereby positions of the transcription factors and the strands they are located is indicated. 
 
 
Figure 11: Possible Transcription factors (TF’s) of Snama as predicted by model inspector software from 
Genomatix. 
 
The sequence that was used for the Model Inspector is shown in the figure below with all the 
sequences of the possible transcription factors indicated. The transcription start site (TSS) is 
also indicated in the figure (figure 12). 
39 
 
1     ACACCACCAT CTTCTCAACC TCTGTCGTTC CCACAGCTGT CACTAGATTA ATAACCGCCA 
      TGTGGTGGTA GAAGAGTTGG AGACAGCAAG GGTGTCGACA GTGATCTAAT TATTGGCGGT 
 
61    CCATTCCCGG CCAGCCAGGC CAATCCTTCC CCAACTACTT TCCGCCTCCT TACAATCCAT 
      GGTAAGGGCC GGTCGGTCCG GTTAGGAAGG GGTTGATGAA AGGCGGAGGA ATGTTAGGTA 
 
121   TCGCCTATGT TGGCTAGTTT TTAGGAGCAT CTACGCAAGC GAGAGTGTCT AACCCCATTA      
AGCGGATACA ACCGATCAAA AATCCTCGTA GATGCGTTCG CTCTCACAGA TTGGGGTAAT 
GATA_NKXH_01 
 
181   CTTCTTTGTA ATTAGGAATC CTGTATTATA TTTAAGAACA CGTGCAAATA TCGAAAAGGC 
      GAAGAAACAT TAATCCTTAG GACATAATAT AAATTCTTGT GCACGTTTAT AGCTTTTCCG 
SORY_PAX6_01 
EBOX_SREB_01 
241   GGTGATACAA AAAGCAGTAG ATTTTATTAT ATTGTATGTG CACTTTGTCG CAAAAGTTGT 
      CCACTATGTT TTTCGTCATC TAAAATAATA TAACATACAC GTGAAACAGC GTTTTCAACA 
 
301   TAATGTAAAT ACTCGAGTTA AGACTAAATT AGGATTGCAT CGAATTTTTT GGATCTAAGA 
      ATTACATTTA TGAGCTCAAT TCTGATTTAA TCCTAACGTA GCTTAAAAAA CCTAGATTCT 
 
361   TAAGCAAAAT ATGGTTGTAG TTCGGTTTAA CTGATGTTAA TAAATTTTTG AACCCTTTTA 
      ATTCGTTTTA TACCAACATC AAGCCAAATT GACTACAATT ATTTAAAAAC TTGGGAAAAT 
 
421   TTCCCTAAAT TAGTTTTTCA TTCCGTATTT ACTGCAGCTT AAGAGTTATT TGATTCTTCA 
      AAGGGATTTA ATCAAAAAGT AAGGCATAAA TGACGTCGAA TTCTCAATAA ACTAAGAAGT 
 
481   AATGATCGAT ACTAATAGTT ATACACTGTG TTCCATTCCA CCGTTTCACG CGGAAGAGAA 
      TTACTAGCTA TGATTATCAA TATGTGACAC AAGGTAAGGT GGCAAAGTGC GCCTTCTCTT 
 
541   CCGACAGAAA TGCAGAATTG CTGCCTTTGC AAACAATATA TAGAAATCGA TTCCCAGCTA 
      GGCTGTCTTT ACGTCTTAAC GACGGAAACG TTTGTTATAT ATCTTTAGCT AAGGGTCGAT 
CEBP_EBOX_01      GREF_OCT1_01 
 
601   TGCACATTTA CCAAATGCTT TCCGTTACAA CACTTATCAA CATTATCTAA TAAAGTTCAA 
      ACGTGTAAAT GGTTTACGAA AGGCAATGTT GTGAATAGTT GTAATAGATT ATTTCAAGTT 
 
CAAT_SP1F_01   ETSF_SPF_05 
661   TACTTTCACT TTGTAATATA AATTACACTC CAACATCGAT ATCGATATCT GTGTCTCTAT 
      ATGAAAGTGA AACATTATAT TTAATGTGAG GTTGTAGCTA TAGCTATAGA CACAGAGATA 
 
  HAND_GATA_01        TSS 
721   CGATACCCGC GTGTGCGTTC GCATTTCACA TCTCTGGGGC TTTGGCGTCA CGTTCGCATC 
      GCTATGGGCG CACACGCAAG CGTAAAGTGT AGAGACCCCG AAACCGCAGT GCAAGCGTAG 
PBXC_MYOD_01       BRNF_RXRF_01  
  
781   TCTAGTAAAT TGGAAAAAAA TAAAATCGTC GGAGTTTTTA TGTGCTTGCA GAGTAGTGTA 
      AGATCATTTA ACCTTTTTTT ATTTTAGCAG CCTCAAAAAT ACACGAACGT CTCATCACAT 
 
841   AGTAATTGCT ATTTTTGTGC CAGCTGCTTG CCGGTAGTAA ACAACGCGCG TGAACTGTGA 
      TCATTAACGA TAAAAACACG GTCGACGAAC GGCCATCATT TGTTGCGCGC ACTTGACACT 
 
901   TGCCTTGCAA TCCTCAGCGC AATTCAAGTG CGGTTTAAGT CCGAACGACC CAAGAAACCC 
      ACGGAACGTT AGGAGTCGCG TTAAGTTCAC GCCAAATTCA GGCTTGCTGG GTTCTTTGGG 
Figure 12: Snama sequences indicating the possible transcription factors. The TSS is indicated in red and 
labelled TSS. The possible transcription factors are labelled and indicated in various colours. 
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3.6. The effect of cells treated with DNA damaging agents. 
Growth of Cos7 cells, derived from the kidney of the African green monkey, was monitored 
using the Xcelligence system (Acea). This system monitors growth of cells in real time. The 
normal growth pattern of these cells is observed in figure 13. The experiment was carried out 
in normal growth media under normal growth conditions and was performed in duplicates. 
The graph shows the expected shape for healthy growing cells. It depicts the growth trends 
for cell growth; the lag phase, log phase (exponential phase), stationary phase and eventually 
the death phase. The results show that the cells used were healthy and that the doubling rate 
for the cells is approximately 8 hours in the log phase. 
 
 
Figure 13: The growth curve of primary Cos7 cells. The cells were reared at 37˚C in normal growth media. 
From the curve it could be determined that the cells display an average doubling time of approximately 8 hours. 
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Previous work in our lab showed that methyl pyruvate improved the survival of cells that 
recover from treatment with agents such as camptothecin. This phenomenon was 
accompanied by changes in the expression patterns of Dmp53 and SNAMA (Hull & Ntwasa, 
2010). 
As the xCELLigence system (Acea) is a system that allows real time monitoring of cells 
whilst conducting experiments. The system continuously and non-invasively detects cell 
responses throughout the experiment without the use of exogenous labels that can potentially 
disrupt the natural cell environment. The system also allows for better target for treatments 
with agents as the growth of cells is monitored in real time when the cells are in the 
incubator. The technology uses gold plated plates with two separable sections, the upper and 
lower chamber. Cells are seeded in the upper chamber and move to the lower chamber 
through the microporous membrane. Cells adhere to the microelectrode sensors and lead to an 
increased impedance that is measured in real time. Applications for the system include;  
 Cell invasion and migration assays 
 Compound and cell-mediated cytotoxicity 
 Cell adhesion and spreading 
 Cell viability, proliferation, and differentiation 
 Receptor-mediated signaling 
 Virus-mediated cytopathogenicity 
 Cardiotoxic compound effects 
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 High-throughput screening 
 Continuous quality control of cells in culture (www.aceabio.com). 
Figure 14 (A-D) shows the effect of different concentrations of camptothecin on the growth 
of transfected Cos7 cells. It appears that regardless of the concentration used the cells 
mortality levels increase following camptothecin exposure. The higher the concentration the 
faster the cells die. However, the DMSO control showed the presence of the solvent killed the 
cells at rates similar to the lower concentration (1µM) of camptothecin.  Therefore, we cannot 
conclusively state that the increase in mortality is due to the presence of camptothecin. So in 
this experiment we observe that: 
 (i) DMSO, the solvent used for camptothecin, inhibited cell multiplication (figure 
14) 
 (ii) It is evident methyl pyruvate has the same effect as normal untreated cells. The 
cells were not affected and grew normally  
 (iii) Furthermore, methyl pyruvate tends to improve the recovery process of DNA 
damaged cells. This is evident in all the experiments using methyl pyruvate 
treatments 
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Figure 14: Treatment of Cos7 cells, transfected with plasmids containing different potential Snama promoters, 
with camptothecin, methyl pyruvate or a combination of both. In all cases the cells continue to grow at an 
exponential rate even after the addition of 1mM methyl pyruvate.. The DMSO control shows that DMSO at 1% 
final concentration is having a lethal effect on all cells. The cells exposed to higher camptothecin concentrations 
show a slight increase in mortality compared to DMSO alone. Methyl pyruvate seems to increase the survival 
rate of cells exposed to higher camptothecin concentrations. 
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4. Discussion  
In this work the putative promoter region of Snama has been shown experimentally to drive 
transcription of a fused luciferase gene. Furthermore, electrophoretic mobility shift assays 
show that a subset of cellular proteins binds to this region suggesting the presence of 
transcription factor binding sites in this region. This is the first time that Snama promoter 
activity has been reported. Therefore, a window has been opened for further studies on the 
regulation of Snama. The bioinformatics assessment of potential transcription factor binding 
sites is limited by the fact that a mammalian database was searched. Further studies should 
focus on Drosophila Transfac databases perhaps using the Patch programme provided by 
Biobase. 
 
4.1. The region immediately upstream the SNAMA TSS has promoter 
activity.   
The main aim of this study was to determine the maximum promoter sequence needed to 
drive expression of Snama. The truncated promoter segments of Snama were tested for 
promoter activity using the luciferase assays. Clear promoter activity was indicated by the 
fragment named ‘promoter 6’ (P6). 
 
The dual luciferase assay measures the change in luminescence when gene expression has 
occurred. For improved accuracy this assay also incorporates renilla luminescence 
measurement which can be used as an internal experimental control. The smaller truncations 
of the putative promoter region (Promoters 1, 2, 3 and 4) showed little or no ability to drive 
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transcription of either luciferase or renilla. This could be due to the fact that they lack the 
sites for core promoter elements required for minimal promoter activity. Promoter 5, located 
at position 454 upstream of the TSS (see figure 8) showed the least significant activity. This 
promoter sequence appears to have a TATA box at around position 195 upstream of the TSS 
(see figure 12). The TATA box is the binding site for DNA polymerase during initiation of 
transcription but requires the presence of core general transcription factors to initiate basal 
transcription activity. These may be lacking in this fragment. 
 
4.2. Factors binding to promoter fragment represented by promoter (P6) 
seem to have positive impact on gene transcription. 
The promoter sequence in Snama designated promoter 6 (P6) extends to position 552 
upstream of the TSS and gave rise to the greatest Luciferase activity indicating the ability to 
induce the highest levels of transcription. These transcription levels were significantly higher 
than those observed in the control. We can therefore, confidently state that the positive 
regulatory region of Snama is located 552 bases upstream from the transcriptional start site. 
  
When EMSA was conducted, P6 appeared to bind more nuclear proteins than P5 and P7 with 
P7 binding more proteins than P5. Notably, despite P7 being the longest promoter sequence 
and containing the full length sequence of P6 and an additional sequence it gave lower 
activity than P6, with EMSA showing less proteins binding as compared to P6. This leads us 
to conclude that this region probably contains a negative regulatory element which inhibits 
the transcription of the luciferase gene.  
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4.3. Promoter analysis 
A bioinformatics search reveals potential sites for binding of transcriptional factors that 
regulate cell proliferations, patterning along the anteroposterior axis, mesoderm development 
and sex determination. An analysis of the transcription factors identified in this process 
shows that they have common functions in multiple associated biological processes. Many of 
these transcription factor models interact with each other through the JAK-STAT pathway to 
control developmental processes (Johnson et al, 2011; Liu et al, 2009). RNA PolII promoters 
usually consist of multiple binding sites for transcription factors which mediate the promoter 
function. Frameworks are sets of sequences that share a common orientation and distance 
organization between a set of related sequences. 
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Model Name Position Strand Drosophila homolog Function Reference 
HAND GATA  26-54 +    
HAND Hand 1) Negative regulator of apoptosis. 
2) Transcription regulation.  
3) Embryonic\ larval development 
4) Hemopoisis 
(Han & Olson, 2005) 
 GATA factor Pannier  1) Development 
2) Cellular biosynthesis regulation 
3) Pigment metabolism 
(Fromental-Ramain et al, 2008) 
 GATA factor Serpent 1) Development including  
2) Hemapoisis 
3) Immune system 
4) Cellular process 
(Muratoglu et al, 2007) 
PBXC MYOD 50-29 -    
MYOD nautilus CG10250 1) Transcription regulation 
2) Muscle development 
(Berkes et al, 2004), (Enriquez 
et al, 2012) 
 PBX Ultrabithorax 1) Development   
2) RNA metabolism 
(Assa-Munt et al, 1993; 
Duboule, 2007)  
BRNF RXRF 60-12  -    
 Multiple POU domain 
containing proteins 
exist in Drosophila. 
For example drifter 
1) Development  
2) Antimicrobial peptide synthesis 
3) Positive regulation of transcript elongation from 
RNA polymerase II promoter 
(Andersen & Rosenfeld, 2001; 
Assa-Munt et al, 1993) 
 Ultraspiracle shares 
47.9 % identity with 
the RXRF homolog 
from the locust L 
migratora 
1) Development 
2)  Metabolism of organic compounds 
3)  Reproduction 
(Ahuja et al, 2003) 
CAAT SP1F 76-112  +    
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SP1F D-Sp1 
Armadillo like helical 
Zinc finger containing 
Transcription Factor 
1) Imaginal disc-derived leg morphogenesis 
2) Regulation of transcription 
(Narayan et al, 1997), 
(Schaeper et al, 2010), (Tseng 
et al, 2013) 
ETSE SP1F 76-112  +    
 There are at least 9 
members of the ETS 
transcription factor 
family present in 
Drosophila an example 
is the protein Pointed 
1) Development                              
2) RNA metabolism  
3) Reproduction 
(Boisclair Lachance et al, 2014) 
EBOX SREB  216-489  +  SREB Transcription factors are involved in  
1) cholesterol biosynthesis  
2) Fatty acid uptake and biosynthesis  
3) membrane biosynthesis 
 
 srebp 1) Phagocytosis  
2) Fatty acid biosynthesis 
3) Positive regulation of transcription  
4) Cell morphogenesis 
5) Signaling pathways 
 
(Parraga et al, 1998) 
 An example of a 
Transcription factor 
that binds to E Boxes 
Bmal1/ Cycle 
1) Biological regulation 
2) rhythmic process; response to stimulus; positive 
regulation of cellular biosynthetic process; 
regulation of RNA metabolic process; positive 
regulation of nucleobase-containing compound 
metabolic process; response to organic substance; 
response to nutrient levels; locomotory behavior; 
(Abruzzi et al, 2011) 
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response to starvation; negative regulation of 
cellular biosynthetic process; adult behavior; 
cellular process; single-organism developmental 
process. 
 Another example of a 
protein that binds to E 
boxes cMyc 
diminutive,  
MyoD 
1) Development                               
2) Cell cycle regulation 
3) Reproduction 
(Parisi et al, 2013) 
GREF OCT1 POU TF 
family 
231-184  
 
- Nubbin 
 
1) Development 
2) Regulation of transcription from RNA polymerase 
II promoter 
(Li & Popadić, 2004) 
CEBP EBOX  239-216 -   (Rørth et al, 2000) 
CCAAT-enhancer-binding 
proteins (or C/EBPs) 
slbo-PB 
C/EBP 
1) Border follicle cell migration 
2) JAK STAT kinase regulation 
3) Cell fate determination 
4) Transcription regulation 
5) regulation of transcription from RNA polymerase 
II promoter 
SORY PAXB 592-549  -  eyeless 
 
Development 
 
( Tanaka-Matakatsu et al, 2015) 
GATA NKXH 651-623 -    
  NKX-homeodomain transcription factors regulate 
organ development 
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Figure 15: Trascription fators (TF's) and their functions.
NKXH Tinman 
 
1) Development commitment (Ryu et al, 2011) 
MYOD VTVB  871-819  - nautilus CG10250  (Berkes et al, 2004; Enriquez et 
al, 2012) 
(vertebrate TATA binding 
Protein) 
TBP-related factor  1) Transcription regulation             (Kedmi et al, 2014) 
57 
 
These transcription factors include the Drosophila homologs of Hand. Hand is involved in 
the negative regulation of apoptosis, embryonic and larval development and the regulation of 
transcription. It is activated by the GATA factors, Pannier and Serpent both of which are also 
involved in development (Han & Olson, 2005). A binding site for Brn POU domain 
transcription factors (BRNF) was also identified. Pou domain containing proteins are DNA 
binding transcription factors that function in the neuroendocrine system as well as in organ 
development (Muratoglu et al, 2007). There are multiple POU domain- containing proteins 
found in Drosophila. The POU domain interacts with other proteins and in the case of the 
SNAMA promoter, it is predicted to allow the binding of a RXRF transcription factors. These 
transcription factors are involved in a variety of signalling pathways which are primarily 
related to metabolism, cell differentiation and cell death 
 
Another transcription factor predicted to bind to the regulatory region of Snama is Nautilus. 
This is the Drosophila homolog of the MyoD. MyoD binds to myogenin promoter through 
domains which interact specifically with an adjacent protein complex containing the 
homeodomain protein Pbx. This transcription factor is involved in muscle development as 
well as the regulation of transcription (Fromental-Ramain et al, 2008). Here Nautilus is 
predicted to be under the control of either Pbx homeodomain proteins such as ultrabithorax 
(Enriquez et al, 2010) or POU domain proteins such as Nubbin in Drosophila. As mentioned 
previously Pou domain containing proteins have a wide variety of functions including 
development (Li & Popadić, 2004; Muratoglu et al, 2007). Other proteins that were predicted 
to associate with MyoD to potentially initiate SNAMA transcription are the vertebrate TATA 
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binding Protein VTVB (Tapscott et al, 1992). The Drosophila homolog TBP related factor 1 
is also predicted to be involved in transcriptional regulation (Kedmi et al, 2014) 
 
The SP1 transcription factor in humans is involved in cell differentiation, cell growth, 
apoptosis, immune responses, response to DNA damage, and chromatin remodeling (Chae et 
al, 2014). The Sp1 homolog could interact with a member of the ETS transcription factor 
family or directly through a CAAT box, whose presence was identified in the promoter 
region (Gegonne et al, 1993). The ETS family is known to be involved in cellular 
differentiation, cell cycle control, cell migration, cell proliferation and apoptosis (Boisclair 
Lachance et al, 2014). 
 
 The Sterol Regulatory Element-Binding Proteins (SREBPs). SREBPs have a structure 
similar to E-box-binding helix-loop-helix (HLH) proteins (Parraga et al, 1998). A Drosophila 
homolog known as Srebp or Helix loop helix protein 106 is involved in the innate immune 
system, metabolism and cellular morphogenesis (Parraga et al, 1998). Further E box binding 
proteins present in Drosophila that are associated with development include the Cycle protein 
which controls cell cycle progression and development (Abruzzi et al, 2011) and the 
diminutive protein (Parisi et al, 2013). Another transcription factor family that is predicted to 
potentially associate with the E box contained within the SNAMA promoter region is the 
CCAAT-enhancer-binding proteins (or C/EBPs). A Drosophila homolog is responsible for 
Border follicle cell migration, cell fate determination and transcription regulation (Parisi et al, 
2013) The PAXb transcription factor is also predicted to have a potential binding site within 
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the Snama promoter region. The Drosophila homolog of this protein Eyeless is involved in 
the development of the eye and general organ development ( Tanaka-Matakatsu et al, 2015).  
 
Binding sites were also identified for Tinman, a NKX homeodomain factor. These 
transcription factors operate in a positive feedback loop with GATA transcription factors and 
are responsible for heart development in vertebrates and in Drosophila it is involved in the 
development of the cardiac and digestive system (Ryu et al, 2011). 
  
Previous studies have highlighted roles for SNAMA in nucleic acid metabolism, transcription 
during development and cell cycle control. Many of the transcription factor frameworks 
identified above play roles in these processes. Although, these transcription factors binding 
sites are predicted by a non Drosophila database, they have credible Drosophila homologues. 
This could be confirmed by a more rigorous analysis using invertebrate transcription factor 
databases. 
 
4.4. Role in apoptosis 
The real time cell assays performed using the xCELLigence system laid the groundwork for 
future studies on the role played by SNAMA during apoptosis. These initial trials showed that 
transfection with the reporter plasmids fused to the promoter did not alter the effects that 
camptothecin, methyl pyruvate or a combination of both on the Cos7 cells. These compounds 
had the same effect on the cells with or without the transfection with the reporter plasmids. 
They were performed as a pilot study based on earlier reports that SNAMA undergoes altered 
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regulation upon camptothecin and methylpyuravte treatment of adult Drosophila. Future 
work can be carried out with the promoter fused to Snama and followed by treatment of the 
cells with these compounds. Alteration in the expression of Snama would then be correlated 
with changes in cell growth and/or survival. As the xCELLigence assays show, camptothecin 
alone and in combination with methyl pyruvate, resulted in cells presenting a typical 
apoptosis response growth curve this treatment on cells that overexpress Snama would help to 
confirm the role played by SNAMA during apoptosis.  
 
 The hypothesis is that SNAMA plays a role in apoptosis through its association with p53 and 
its functional similarities with Mdm2. In Drosophila no Mdm2 homolog has been detected 
but the mouse homolog of RbBP6, PACT/P2P-R, can negatively regulate p53 by enhancing 
the activity of Mmd2. Both mdm2 null mutants and pact
-/-
 mice die during embryogenesis and 
display widespread apoptosis (Li et al, 2007). Deletion of p53 is able to rescue these mutants 
(de Oca Luna et al, 1995).  
 
While these phenotypes are similar, the phenotype of the pact-/- mice is more severe 
indicating that PACT has additional functions to promoting the activity of Mdm2. For 
example, the pact-/- embryos can only be partially rescued by p53 deletion resulting in 
embryos with a distinct anterior-posterior pattern suggesting an important role for PACT in 
mouse embryonic patterning. Taken together these facts indicate the crucial importance of 
refining the biological role of SNAMA. 
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4.5. Conclusion 
The putative promoter region of SNAMA drives gene expression of the luciferase gene. In 
addition, the possible transcription binding sites were found in this region. However further 
investigation is still required to elucidate the finer aspects of the regulation of Snama. The 
findings of the present study should contribute to understanding the regulation of Snama and 
potentially lead to the development of drugs that can be used to treat life threatening 
conditions such as cancer since SNAMA seems to be involved in apoptosis. 
 
4.6. Future Work 
Replacing the luciferase gene with the Snama in the pGL3 vector prior to transfection might 
give insight to the direct effect of Snama on cell growth and survival and to the mechanism 
by which SNAMA responds to DNA damage. Understanding the interaction between Snama 
and the promoters can possibly lead to the identification of the transcription factors involved 
which will give better insight of the positive or negative role the proteins play in gene 
regulation. 
Since DMSO was found to induce apoptosis in the genotoxic DNA damage experiment, 
across all the promoters investigated, it masks the effect that the promoter may have in 
increasing the levels of apoptosis. It would be better to use an alternative solvent to observe 
the effect of the promoters on Snama in a more insightful manner. Such an alternative would 
be irinotecan which is a water soluble derivative of camptothecin. 
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5. Appendix 
5.1. SNAMA sequence 
1         GCATTTCACATCTCTGGGGCTTTGGCGTCACGTTCGCATCTCTAGTAAATTGGAAAAAAA 
1                    TSS 
61        TAAAATCGTCGGAGTTTTTATGTGCTTGCAGAGTAGTATTTCTTTCATATGCAACTATGT 
21                   M  S 
121       CGGTACACTATAAATTTAAGAGTACACTCAACTTTGATACAATTACTTTTGATGGACTTC 
41           V  H  Y  K  F  K  S  T  L  N  F  D  T  I  T  F  D  G  L  H 
181       ACATTTCTGTCGGGGACTTAAAAAGGGAGATTGTGCAGCAGAAGCGACTGGGCAAAATCA 
61           I  S  V  G  D  L  K  R  E  I  V  Q  Q  K  R  L  G  K  I  I 
 
241       TCGACTTTGATCTCCAAATAACAAATGCGCAGAGTAAAGAAGAATACAAGGACGATGGGT 
81           D  F  D  L  Q  I  T  N  A  Q  S  K  E  E  Y  K  D  D  G  F 
 
301       TCCTTATTCCCAAAAACACAACGCTGATCATATCGCGCATCCCCATCGCCCATCCCACAA 
101          L  I  P  K  N  T  T  L  I  I  S  R  I  P  I  A  H  P  T  K 
 
361       AAAAGGGCTGGGAGCCACCAGCAGCAGAAAATGCCTTTTCGGCGGCGCCTGCCAAGCAGG 
121          K  G  W  E  P  P  A  A  E  N  A  F  S  A  A  P  A  K  Q  D 
 
421       ACAACTTCAACATGGACCTGTCCAAAATGCAAGGCACGGAGGAGGACAAAATCCAGGCCA 
141          N  F  N  M  D  L  S  K  M  Q  G  T  E  E  D  K  I  Q  A  M 
 
481       TGATGATGCAGAGCACAGTCGACTATGATCCTAAGACGTACCATCGTATTAAAGGACAAT 
161          M  M  Q  S  T  V  D  Y  D  P  K  T  Y  H  R  I  K  G  Q  S 
 
541       CGCAAGTGGGAGAAGTTCCCGCATCCTACCGATGCAACAAATGCAAGAAAAGCGGACACT 
181          Q  V  G  E  V  P  A  S  Y  R  C  N  K  C  K  K  S  G  H  W 
 
601       GGATCAAAAACTGTCCCTTTGTGGGGGGAAAGGACCAGCAAGAGGTCAAACGGAATACTG 
201          I  K  N  C  P  F  V  G  G  K  D  Q  Q  E  V  K  R  N  T  G 
 
661       GTATTCCGCGGTCTTTCCGCGACAAGCCAGATGCGGCTGAGAACGAATCAGCCGATTTTG 
221          I  P  R  S  F  R  D  K  P  D  A  A  E  N  E  S  A  D  F  V 
 
721       TGCTGCCTGCTGTACAAAACCAAGAGATACCGGAGGATCTGATATGCGGCATATGCCGAG 
241          L  P  A  V  Q  N  Q  E  I  P  E  D  L  I  C  G  I  C  R  D 
 
781       ATATATTCGTCGATGCTGTCATGATACCCTGCTGCGGAAGTTCCTTTTGTGACGACTGTG 
261          I  F  V  D  A  V  M  I  P  C  C  G  S  S  F  C  D  D  C  V 
 
841       TGCGAACCTCCTTATTGGAGTCAGAGGATAGTGAGTGCCCCGATTGCAAGGAGAAGAACT 
281          R  T  S  L  L  E  S  E  D  S  E  C  P  D  C  K  E  K  N  C 
 
901       GTTCGCCTGGCTCCCTGATACCTAATCGGTTCTTGAGGAATTCGGTGAACGCCTTTAAAA 
301          S  P  G  S  L  I  P  N  R  F  L  R  N  S  V  N  A  F  K  N 
 
961       ATGAGACTGGGTATAACAAAAGCGCGGCTAAGCCAGCTGCAGTAAAAAATGAGGAAAAAC 
321          E  T  G  Y  N  K  S  A  A  K  P  A  A  V  K  N  E  E  K  P 
 
1021      CTCCTGTTGAAAAAGAAGTGGAGAAAAAGCCAGTCGCGGAGGTGGAACCCGAAGAGACTG 
341          P  V  E  K  E  V  E  K  K  P  V  A  E  V  E  P  E  E  T  E 
 
1081      AGGTGAAACCTGAAAAGCAAAAAGAATCCGAAACCAATGGCAGTAATCCGCCAAAATCGG 
361          V  K  P  E  K  Q  K  E  S  E  T  N  G  S  N  P  P  K  S  E 
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1141      AATCTCCAGAGCCTCCCGCAACCACAGAACCATCACAGAAGGAGAAAGATAAATATGATT 
381          S  P  E  P  P  A  T  T  E  P  S  Q  K  E  K  D  K  Y  D  S 
 
1201      CAGACTACGAGGATAACATTACCATAAAAATGCCCCAGCCTGCAGCTGATTCTACAACAG 
401          D  Y  E  D  N  I  T  I  K  M  P  Q  P  A  A  D  S  T  T  V 
 
1261      TGCCCAGCAAAAGATCCCCCAGTTATTCCCACAGAAGTGAATCCTCTCATCGACGGGACA 
421          P  S  K  R  S  P  S  Y  S  H  R  S  E  S  S  H  R  R  D  R 
 
1321      GGTCGGATTATGTTTCCGATCACGATCACAAGCACCAACGTCCATCAAAATCGGAGTCTG 
441          S  D  Y  V  S  D  H  D  H  K  H  Q  R  P  S  K  S  E  S  V 
 
1381      TTAACAAGGATCGCAGTCTCCTGCCCTTGCCCATTGGCACCCTGCCTAGCTACCAGGGCC 
461          N  K  D  R  S  L  L  P  L  P  I  G  T  L  P  S  Y  Q  G  H 
 
1441      ACATGATGGCCGAATCAGAAGAAGCTCGTCGATCGAGTGCCTATAAGCCCCCTTATATGC 
481          M  M  A  E  S  E  E  A  R  R  S  S  A  Y  K  P  P  Y  M  Q 
 
1501      AAATGCAGCGGGGCCCACCTCCTATGCACATGATGAGTCACCACATGCCAGCCTACAACA 
501          M  Q  R  G  P  P  P  M  H  M  M  S  H  H  M  P  A  Y  N  N 
 
1561      ACGGGTTTAACAACATGGGACAGAGGCCTCCCCTCAGCTATGTGCCGTATCAAAACCAAT 
521          G  F  N  N  M  G  Q  R  P  P  L  S  Y  V  P  Y  Q  N  Q  S 
 
1621      CCGTACACCCAATGCGTGCGCCGTACGGATCTGCAGGCGGAGGTATGAATATGAATATGT 
541          V  H  P  M  R  A  P  Y  G  S  A  G  G  G  M  N  M  N  M  S 
 
1681      CACAACCATTTCAGTCCCCAAATTTAGCCTCGATATACCAAGGGGTGGCAGCGAAGGTCG 
561          Q  P  F  Q  S  P  N  L  A  S  I  Y  Q  G  V  A  A  K  V  G 
 
1741      GTTCCGGTCCCATTGACGATCCGTTGGAGGCCTTCAATCGCATCATGAAGGAGAAGGAGC 
581          S  G  P  I  D  D  P  L  E  A  F  N  R  I  M  K  E  K  E  R 
 
1801      GGAAGAAGGTGGACCGCTTTCGAAGCTCTGACCGCCACAGGTCAAGGTCCCCGGATAGAC 
601          K  K  V  D  R  F  R  S  S  D  R  H  R  S  R  S  P  D  R  Q 
 
1861      AAAGGCACCGCTTTAAGTCTCCCATGTACGAAAAGGACAACTCCAGGGATAATCTCAAGG 
621          R  H  R  F  K  S  P  M  Y  E  K  D  N  S  R  D  N  L  K  D 
 
1921      ACAAAAGACCGCGATCCCGGGAAAGGAAGCGAGAACATAGCTACGAACGGCATATACGCC 
641          K  R  P  R  S  R  E  R  K  R  E  H  S  Y  E  R  H  I  R  H 
 
1981      ACCCTCGTTCTAGTCGCCAGCCGAATGATGGCTCTAAGTCCCCAGGTGGCAGAATCAAAA 
661          P  R  S  S  R  Q  P  N  D  G  S  K  S  P  G  G  R  I  K  R 
 
2041      GATCTGGACATCGTCGCTCTGCATCTCCAAAGCCGGGCTACAAGAGTGATTACAGAGACA 
681          S  G  H  R  R  S  A  S  P  K  P  G  Y  K  S  D  Y  R  D  K 
 
2101      AGCCGTACAACAAGCCTAGTGCTCCCAAAACGGAGGCAGTTGAGCCTCCTCCCCCCGGAT 
701          P  Y  N  K  P  S  A  P  K  T  E  A  V  E  P  P  P  P  G  F 
 
2161      TCGAGCCGTTGCAGCTGACGGATGAAGACGGCTACAGGAACAAGCACCCGACCAGTTCGG 
721          E  P  L  Q  L  T  D  E  D  G  Y  R  N  K  H  P  T  S  S  E 
 
2221      AAGCATCACAAAGCAGCAAGGGTGATAGCAGCAAGAAGAGAGGGGAAAACAGGCACGAAG 
741          A  S  Q  S  S  K  G  D  S  S  K  K  R  G  E  N  R  H  E  E 
 
2281      AGGCGCCACGAAAGAGGCACAGGTCTCGCAGCATTAGCAAGGAACCGAAGCCGAATGACA 
761          A  P  R  K  R  H  R  S  R  S  I  S  K  E  P  K  P  N  D  S 
 
2341      GCAACTACAGGAGCCTGACTCCACCAGCAAAGATCACCACACCGAAAATGACTGCTGCCC 
781          N  Y  R  S  L  T  P  P  A  K  I  T  T  P  K  M  T  A  A  Q 
 
2401      AGTTGAGGCAACGCGAAAGTTCACCGAAGACGCCGGAAAAGAGTCACGACGATTATCTGA 
801          L  R  Q  R  E  S  S  P  K  T  P  E  K  S  H  D  D  Y  L  T 
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2461      CCGCGAAGGCCAGAATTATGGCCTCCCAGCCCGTCATCAACGACACGGAAATGGAGACCA 
821          A  K  A  R  I  M  A  S  Q  P  V  I  N  D  T  E  M  E  T  N 
 
2521      ATGTGGGCAAGGAGAACAAGGCCAAGAGTCCGTTGTCAAAAGATCGCAAGAAGAAGAAGA 
841          V  G  K  E  N  K  A  K  S  P  L  S  K  D  R  K  K  K  K  K 
 
2581      AGGACAAGGACAAGGCTGAGCGCAAGAAAAACAAGAAGGACAAGCGCGCTAAGAAGGAGA 
861          D  K  D  K  A  E  R  K  K  N  K  K  D  K  R  A  K  K  E  K 
 
2641      AAGGGGATCGCCAGAAGAAGAGCTCCTCAGTTAATCGATCTGACTCGGATATTAACAACA 
881          G  D  R  Q  K  K  S  S  S  V  N  R  S  D  S  D  I  N  N  S 
 
2701      GCTCACTAATGAACGAGTCAAATTATAAAGTATTGTCTCCCAGGGCTCAAAGTCCCAGCA 
901          S  L  M  N  E  S  N  Y  K  V  L  S  P  R  A  Q  S  P  S  I 
 
2761      TTGAGATCAATGCGGCTCAACTTTCCCCTACTCACAACGCTACTGAAAACGTTAATCCGA 
921          E  I  N  A  A  Q  L  S  P  T  H  N  A  T  E  N  V  N  P  K 
 
2821      AGAGTCATTCCATCCTTACTGTGGGTGCTGCTAGCGACGATAATCTTGGCCCAAGAAGCA 
941          S  H  S  I  L  T  V  G  A  A  S  D  D  N  L  G  P  R  S  K 
 
2881      AACTCAGCGAGGCTAATTCTGTCAATCTATCCAAATGGGAAATCGACGAGAATATCTTAG 
961          L  S  E  A  N  S  V  N  L  S  K  W  E  I  D  E  N  I  L  G 
 
2941      GTTTGGAGGATTCCTCCAAAAAAGCTGCCGGGGCCTCCGACGATCCGTCGGAAATAACTT 
981          L  E  D  S  S  K  K  A  A  G  A  S  D  D  P  S  E  I  T  S 
 
3001      CAGACGTCCTGCGAAAGGCTGAGAACGCAATATTTGCAAAGGCTATTAATGCCATCAGGC 
1001         D  V  L  R  K  A  E  N  A  I  F  A  K  A  I  N  A  I  R  P 
 
3061      CTATGGAGTTTCAAGTTATTATCAATTCCAAGGACAACAGCAAGGACCGCTCCGTAGTTC 
1021         M  E  F  Q  V  I  I  N  S  K  D  N  S  K  D  R  S  V  V  R 
 
3121      GAAGTGACAAGGATCGCTCCTCCTCACCCAGGCGTAACAACAGCAGCAGGTCGGTAAAGG 
1041         S  D  K  D  R  S  S  S  P  R  R  N  N  S  S  R  S  V  K  D 
 
3181      ATAGGCTGGGCACCAAGATTTCCAATGATAGAAGCCGTTCGCGAGACAAGTCGAAGGGCA 
1061         R  L  G  T  K  I  S  N  D  R  S  R  S  R  D  K  S  K  G  R 
 
3241      GGCGCCGGGCCGCAAGGAGCTCCGACGACGATGCGAACCGCGGCAGGTCGGATCGTCATG 
1081         R  R  A  A  R  S  S  D  D  D  A  N  R  G  R  S  D  R  H  G 
 
3301      GCAGCCGGAAGAGGGACAACAGATCCCGCGACAGGGCGGCGCCTTCAGAGAAGAGGCAGG 
1101         S  R  K  R  D  N  R  S  R  D  R  A  A  P  S  E  K  R  Q  E 
 
3361      AGCGTTCGTACAAGCGAAGCTCGCCGGAGGACGACAAGCTGAGGCGCCAGAACAAGGAAC 
1121         R  S  Y  K  R  S  S  P  E  D  D  K  L  R  R  Q  N  K  E  Q 
 
3421      AGTCCGAATCCAAGCACGGAAAGCATGATCAAAACAATAGCGACGACTCGGATCGGAGGG 
1141         S  E  S  K  H  G  K  H  D  Q  N  N  S  D  D  S  D  R  R  A 
 
3481      CGGCCAAAAACACCAAGTCCAGCGACAGCCGAGTGGTCTCCTCTGTAACAGCCGTGGTTG 
1161         A  K  N  T  K  S  S  D  S  R  V  V  S  S  V  T  A  V  V  A 
 
3541      CTCCTCCCAAACCCTGTCGTCCAGACAACCCGTTCCGCAAGTTCGTCGACACCAGTTCGT 
1181         P  P  K  P  C  R  P  D  N  P  F  R  K  F  V  D  T  S  S  S 
 
3601      CGAGCAGCTTAGTTGTAAAATATGATAACACGATACAGAAGGAGGGCGCGTCCTCGGACA 
1201         S  S  L  V  V  K  Y  D  N  T  I  Q  K  E  G  A  S  S  D  N 
 
3661      ACGGCATGGAGCACAGGAAGCAGAGGGATAAGAAGCTGAAGAAACATTCAAAATATTCGT 
1221         G  M  E  H  R  K  Q  R  D  K  K  L  K  K  H  S  K  Y  S  S 
 
3721      CAACCGATTCGTTGAAGAGCGAGAAGCGCAAGGATCCGAAGAGCAAAAAGAAGAGCAAGA 
1241         T  D  S  L  K  S  E  K  R  K  D  P  K  S  K  K  K  S  K  I 
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3781      TTTTGAAGAAGAAGAAAAAATCAAAGAAGTAGGTTACGGTAGGCTACGAGATAAGAATGA 
1261         L  K  K  K  K  K  S  K  K  *  V  T  V  G  Y  E  I  R  M  I 
 
3841      TATAAATATTGAAGATTAATGTGTACAAATCAAAGATTTTTAATGTATGTATTTATCATG 
1281         *  I  L  K  I  N  V  Y  K  S  K  I  F  N  V  C  I  Y  H  A 
 
3901      CAACTATAAGTATACAAATAAAACAGAACTACTC 
1301         T  I  S  I  Q  I  K  Q  N  Y   
 
 
The nucleic acid and amino acid sequence of SNAMA with DWNN, zinc and RING finger 
motif in green, blue and red respectively. The transcription start site is highlighted in a purple 
block. 
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5.2. Vectors 
 
pGem-T-Easy circle map (Promega)   pGL3-Basic vector circle map (Promega) 
pGL3-Enhancer vector circle map (Promega) pGL3-Promoter vector circle 
map(Promega)
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pGL3-Control vector circle map (Promega)  pRL-TK vector circle map (Promega)  
 
pRL-SV40 vector circle map (promega)   
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pRL-null vector circle map (promega)  pRL-CVM vector circle map (promega)
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GeneRuler 100bp (Fermentas)   GeneRuler 1kb (Fermentas) 
PageRuler prestained protein ladder (Fermentas) 
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